Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report 2026-2033

The global pharmaceutical analytical testing services in CRO market size was valued at USD 8.0 billion in 2025 and is projected to grow from USD 8.7 billion in 2026 to USD 15.9 billion by 2033, at a CAGR of 9.1% from 2026 to 2033. North America dominated the market, accounting for the largest share of 37.2% in 2025.

The pharmaceutical analytical testing services in CRO industry is anticipated to grow over the forecast period owing to increasing outsourcing of analytical testing by pharmaceutical and biotechnology companies, stringent global regulatory requirements for product quality and safety, rising development of biologics, biosimilars, and advanced therapies, growing pharmaceutical research and development activities, and expanding demand for specialized analytical capabilities across the drug development lifecycle. The market growth is further supported by the need to reduce development timelines, optimize operational costs, and access advanced analytical technologies without major capital investment. The increasing complexity of pharmaceutical formulations and regulatory expectations continues to drive the outsourcing of analytical testing services to specialized CROs.

The increasing outsourcing of pharmaceutical analytical testing remains one of the primary growth drivers for the market. The growing complexity of drug development, coupled with strict regulatory requirements for analytical method validation, stability testing, impurity profiling, and bioanalytical assessments, has encouraged pharmaceutical companies to partner with specialized CROs that offer advanced laboratory infrastructure and regulatory expertise. The outsourcing model enables companies to reduce operational costs, improve resource utilization, and accelerate product development timelines while maintaining regulatory compliance. For instance, in May 2025, SGS announced ISO 17025 accreditation for its pharmaceutical laboratory in Mississauga, Canada, enabling the facility to provide extractables and leachables testing services for pharmaceutical, biopharmaceutical, and medical device manufacturers across North America, thereby expanding analytical testing capacity to address increasing client demand.

The increasing development of biologics, biosimilars, cell and gene therapies, and other complex drug modalities is another significant factor supporting market growth. These products require sophisticated analytical characterization, bioanalytical testing, stability assessment, and regulatory documentation throughout development and commercialization, creating sustained demand for specialized CRO services. The growing number of clinical development programs involving complex biologics has further increased the need for advanced analytical technologies and scientific expertise. For instance, in June 2025, Svar Life Science and Lablytica Life Science entered a strategic partnership to expand regulated bioanalytical services with advanced LC-MS-MS capabilities for pharmacokinetic, pharmacodynamic, biomarker quantification, and therapeutic drug monitoring studies across drug discovery and clinical development programs.

The market growth is moderated by high investment requirements for advanced analytical laboratories, evolving regulatory expectations, and the limited availability of highly skilled analytical scientists with expertise in complex testing methodologies. The increasing pipeline of biologics and advanced therapies, continued outsourcing by emerging biotechnology companies, and ongoing investments in analytical laboratory expansion and regulatory consulting services are expected to create significant growth opportunities for pharmaceutical analytical testing service providers. The combination of increasing pharmaceutical outsourcing, expanding biologics development, stringent quality requirements, and continuous investments in analytical capabilities is expected to support the sustained market growth over the forecast period.

Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end-use, and region:

Service Outlook (Revenue, USD Million, 2021 - 2033)

Bioanalytical Testing
Clinical
Non-Clinical
Method Development & Validation
Extractable & Leachable
Impurity Method
Technical Consulting
Others
Stability Testing
Drug Substance
Stability Indicating Method Validation
Accelerated Stability Testing
Photostability Testing
Others
Others

End-use Outlook (Revenue, USD Million, 2021 - 2033)

Pharmaceutical Companies
Biopharmaceutical Companies
Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Poland
Switzerland
Austria
Czech Republic
Croatia
Slovenia
Greece
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
UAE
Saudi Arabia
Kuwait
Qatar
Oman

Why should you buy this report?

Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
Competitive Landscape: Explore the market presence of key players.
Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

Market intelligence to enable effective decision-making
Market estimates and forecasts from 2018 to 2030
Growth opportunities and trend analyses
Segment and regional revenue forecasts for market assessment
Competition strategy and market share analysis
Product innovation listing for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Chapter 1. Research Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis

Chapter 4. Pharmaceutical Analytical Testing Services in CRO Market: Service Estimates & Trend Analysis

4.1. Pharmaceutical Analytical Testing Services in CRO Market, Service: Segment Dashboard
4.2. Pharmaceutical Analytical Testing Services in CRO Market, Service: Movement Analysis
4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, Service, 2021 - 2033 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Non-Clinical
4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Method Development & Validation
4.5.1. Method Development & Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Extractable & Leachable
4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pharmaceutical Analytical Testing Services in CRO Market: End Use Estimates & Trend Analysis

5.1. Pharmaceutical Analytical Testing Services in CRO Market, End Use: Segment Dashboard
5.2. Pharmaceutical Analytical Testing Services in CRO Market, End Use: Movement Analysis
5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, End Use, 2021 - 2033 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis

6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2025 & 2033
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Competitive Scenario
6.4.10.3. Regulatory Framework
6.4.10.4. Poland Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Competitive Scenario
6.4.11.3. Regulatory Framework
6.4.11.4. Switzerland Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Competitive Scenario
6.4.12.3. Regulatory Framework
6.4.12.4. Austria Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Competitive Scenario
6.4.13.3. Regulatory Framework
6.4.13.4. Czech Republic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Competitive Scenario
6.4.14.3. Regulatory Framework
6.4.14.4. Croatia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Competitive Scenario
6.4.15.3. Regulatory Framework
6.4.15.4. Slovenia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Competitive Scenario
6.4.16.3. Regulatory Framework
6.4.16.4. Greece Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Australia
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Thailand
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. South Korea
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. UAE
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.6. Qatar
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.7. Oman
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Key Participant Categorization
7.1.1. Market Leaders
7.1.2. Emerging Players
7.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
7.3. Company Profiles
7.3.1. SGS Société Générale de Surveillance SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Worldwide Clinical Trials
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Sofpromed
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. ClinChoice
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Evotec
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Eurofins Scientific
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. KYMOS Group
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. ViviaBiotech S.L.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. GalChimia
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. TCI Laboratories
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Cotecna (NEOTRON SpA,)
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Tentamus
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Enzymlogic
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Pharmbiotest
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. UNIFARM - Research Centre
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. ANAPHARM EUROPE, S.L.U
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Region, 2021 - 2033 (USD Million)
Table 4. Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 5. Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 6. North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 7. North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 8. North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 9. U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 10. U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 11. Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 12. Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 13. Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 14. Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 15. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 16. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 17. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 18. UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 19. UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 20. Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 21. Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 22. France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 23. France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 24. Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 25. Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 26. Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 27. Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 28. Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 29. Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 30. Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 31. Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 32. Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 33. Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 34. Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 35. Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 36. Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 37. Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 38. Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 39. Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 40. Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 41. Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 42. Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 43. Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 44. Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 45. Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 46. Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 47. Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 48. Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 49. Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 50. Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 51. Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 52. Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 53. China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 54. China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 55. India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 56. India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 57. Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 58. Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 59. South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 60. South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 61. Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 62. Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 63. Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 64. Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 65. Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 66. Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 67. Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 68. Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 69. Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 70. Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 71. Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 72. Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 73. South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 74. South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 75. Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 76. Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 77. UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 78. UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 79. Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 80. Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 81. Oman Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 82. Oman Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)
Table 83. Qatar Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, Service, 2021 - 2033 (USD Million)
Table 84. Qatar Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, End Use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2025 (USD Billion)
Figure 15 Ancillary market outlook, 2025 (USD Billion)
Figure 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
Figure 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
Figure 21 Bioanalytical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 22 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 23 Non-Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 24 Method Development & Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 25 Extractable & Leachable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 26 Impurity Method Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 27 Technical Consulting Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 28 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 29 Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 30 Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 32 Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 33 Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 34 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 35 Others Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
Figure 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
Figure 38 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 40 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 41 Regional Marketplace: Key Takeaways
Figure 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 43 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 44 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 45 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 46 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 47 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 48 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 49 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 50 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 51 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 52 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 53 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 54 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 55 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 56 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 57 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 58 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 59 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 60 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 61 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 62 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 63 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 64 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 65 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 66 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 67 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 68 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 69 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 70 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 71 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 73 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 74 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 75 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 76 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 77 Oman Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 78 Qatar Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Companies Mentioned

SGS Société Générale de Surveillance SA
Worldwide Clinical Trials
Sofpromed
ClinChoice
Evotec
Eurofins Scientific
KYMOS Group
ViviaBiotech S.L.
GalChimia
TCI Laboratories
Cotecna (NEOTRON SpA,)
Tentamus
Enzymlogic
Pharmbiotest
UNIFARM - Research Centre
ANAPHARM EUROPE, S.L.U

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5475EUR$5,950USD£4,573GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6395EUR$6,950USD£5,341GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8235EUR$8,950USD£6,878GBP

Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation

Service Outlook (Revenue, USD Million, 2021 - 2033)

End-use Outlook (Revenue, USD Million, 2021 - 2033)

Regional Outlook (Revenue, USD Million, 2021 - 2033)

Why should you buy this report?

This report addresses:

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report by Type, Service, Therapeutic Area, Molecule, Region, and Segment Forecasts, 2026-2033

Biologics Contract Research Organizations Market Size, Share & Trends Analysis Report by Type, Product, Service, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033

Preclinical Imaging Industry Analysis, Size, Share, Growth, Trends, and Forecast 2026-2033 - (by Product Type, Application, End-User, Geographic Coverage and by Company)

Global Drug Discovery Platforms Market Size, Share & Industry Analysis Report by Drug Type, End Use, Application, Therapeutic, Regional Outlook and Forecast, 2026-2033

Contract Research Organization Services Market by Type, Therapeutic Area, Modality, Model, End User, Competition - Global Forecast to 2031